Anupa R Menjoge

Title: Anupa R Menjoge: Innovator in Hydrogel and Nanocarrier Technologies

Introduction

Anupa R Menjoge is a prominent inventor based in Highland Park, NJ (US). She has made significant contributions to the fields of hydrogel formulations and nanocarrier technologies. With a total of 3 patents to her name, her work focuses on innovative solutions for drug delivery systems.

Latest Patents

Anupa's latest patents include a hydrogel formulation designed for dermal and ocular delivery. This formulation consists of cross-linkable polymers that can create non-toxic and biocompatible hydrogels in situ. These hydrogels contain therapeutic agents such as doxycycline or minocycline. The methods disclosed in her patent aim to treat skin or ocular tissues of mammals that have been exposed to harmful vesicant compounds like sulfur mustard (SM) and nitrogen mustard (NM).

Another notable patent involves novel classes of multi-arm polyalkylene oxide-based materials, including PEG nanocarriers and nanogel particles. These compositions can be associated with therapeutic agents and targeting moieties, enhancing their effectiveness. The PEG-based materials are designed to provide high drug loads with improved solubility and targeted delivery.

Career Highlights

Anupa R Menjoge is affiliated with Rutgers, the State University of New Jersey, where she continues her research and development in innovative drug delivery systems. Her work has garnered attention for its potential applications in medical treatments.

Collaborations

Anupa has collaborated with notable colleagues, including Patrick J Sinko and Stanley Stein, contributing to the advancement of her research and the development of her patented technologies.

Conclusion

Anupa R Menjoge is a trailblazer in the field of hydrogel and nanocarrier technologies. Her innovative patents reflect her commitment to improving drug delivery systems for better therapeutic outcomes.